significant proportions of our patients with secondary cns lymphoma had other features which were known to be associated with a high risk of cns disease including stage iv ( 48/51 , 91.4 % ) , bone marrow ( 26/51 , 50.9 % ) , peripheral blood ( 7.51 , 13.7 % ) , nasal ( 7/51 , 13.7 % ) , orbital ( 3/51 , 5.9 % ) , testicular ( 2/51 , 3.9 % ) and bulky retroperitoneal ( 6/51 , 11.8 % ) disease .
C2981383
secondary cns lymphoma
C3714787
cns